DUBLIN–(BUSINESS WIRE)–The “Vasomotor
Symptoms of Menopause – Pipeline Insight, 2019” drug pipelines
has been added to ResearchAndMarkets.com’s offering.
The report offers comprehensive Insight of the pipeline (under
development) therapeutics scenario and growth prospects across Vasomotor
Symptoms of Menopause development.
The report provides detailed coverage of the pipeline landscape for this
mechanism of action, equipped with data from multiple sources with
complete pipeline analysis by developmental stage, associated
indications, route of administration and molecule type.
Pipeline therapeutics development coverage provides descriptive product
profiles including (but not limited to) drug description, product
development and R&D activities encompassing clinical and pre-clinical
studies, designations, collaborations, licensing deals, grants,
technologies and patent details.
The report assesses the active Vasomotor Symptoms of Menopause pipeline
products by developmental stage, product type, molecule type, and
administration route.
Scope of the report
-
The report provides a snapshot of the pipeline development for the
Vasomotor Symptoms of Menopause -
The report covers pipeline activity across the complete product
development cycle i.e. clinical, pre-clinical and discovery stages for
the Vasomotor Symptoms of Menopause -
The report provides pipeline product profiles which includes product
description, developmental activities, licensors & collaborators and
chemical information -
Provides pipeline assessment by monotherapy and combination therapy
products, stage of development, route of administration, and molecule
type for Vasomotor Symptoms of Menopause -
The report also covers the dormant and discontinued pipeline projects
related to the Vasomotor Symptoms of Menopause
Key Topics Covered:
1. Report Introduction
2. Vasomotor Symptoms of Menopause Overview
3. Pipeline Therapeutics
- An Overview of Pipeline Products for Vasomotor Symptoms of Menopause
4. Comparative Analysis
5. Products in Clinical Stage
- Product Description
- Research and Development
- Product Development Activities
6. Products in Pre-Clinical and Discovery Stage
- Product Description
- Research and Development
- Product Development Activities
7. Therapeutic Assessment
- Assessment by Route of Administration
- Assessment by Stage and Route of Administration
- Assessment by Molecule Type
- Assessment by Stage and Molecule Type
8. Inactive Products
- Product Description
- Research and Development
- Product Development Activities
Companies Mentioned
- Endoceutics
- Therapeutics MD
- Nerre Therapeutics Ltd.
- Radius Health Inc.
- Pherin Pharmaceuticals Inc.
- Mithra Pharmaceuticals.
- Euroscreen S.A
- Yung Shin Pharmaceutical
- Ausio Pharmaceuticals
- Millendo Therapeutics Inc.
- MenoGeniX Inc
- Mitsubishi Tanabe Pharma Corporation
- Fervent Pharmaceuticals
- QUE Oncology
- Hibernaid Inc.
- Eaton Scientific Systems
For more information about this drug pipelines report visit https://www.researchandmarkets.com/r/ox12pi
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Women’s
Health, Sexual
and Reproductive Health Drugs